CCL2 and diabetic kidney disease: Alternatively, the NF-κB pathway may, at least in part, be more important since its down-regulation, as well as the down-regulation of its downstream target Ccl2, was associated with the renoprotective actions of metformin and canagliflozin in DKD development.